Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma

BACKGROUND: Pulmonary sarcomatoid carcinoma (PSC) is a heterogeneous disease with poor prognosis. It is essential to understand the molecular basis of its progression in order to devise novel therapeutic strategies. The aim of this study was to identify the pathological mutations in PSC through next...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yingying, Duan, Xiumei, Wang, Shuai, He, Hua, Lan, Shijie, Guo, Zhen, Wu, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710017/
https://www.ncbi.nlm.nih.gov/pubmed/36447228
http://dx.doi.org/10.1186/s12890-022-02248-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710017/
https://www.ncbi.nlm.nih.gov/pubmed/36447228
http://dx.doi.org/10.1186/s12890-022-02248-9

Ejemplares similares